Drug Farm’s ALPK1 inhibitor DF-003 is being investigated in a Phase I trial for ...
If new treatments are shown to maintain weight loss, they will become game chang...
MSD’s blockbuster immunotherapy, set to lose patent protection in 2028, secures ...
The acquired programme consists of antibiotics against gram-negative bacteria, i...
PCM Trials, a Denver, USA based leader in providing mobile research nurses for d...
Arena Bioworks has already lured top scientists from academic labs, raising some...
What STAT readers think about JPM's locked lactation room, covering weight loss ...
CA 15-3 is an epitope of the MUC1 glycoprotein. MUC1 is a transmembrane mucosa-a...
In the ever-evolving landscape of cancer treatment, recent breakthroughs in the ...
Alcon’s recent acquisition of Aerie Pharmaceuticals for $770 million is proving ...
The UK nod for Agamree, which comes after previous approvals in Europe and the U...
Dermavant will include these findings in an upcoming supplemental new drug appli...
Ji Xing Pharmaceuticals acquired Biogen’s BIIB131 for advancing worldwide clinic...
Contract research organisation ClinChoice has acquired CSI Medical Research, mar...
Cereno Scientific has announced a partnership with CordenPharma to scale up manu...
SyntheticGestalt and Enamine have announced a collaboration to develop a suite o...
